Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What CAGR Is Anticipated for the Hormone Therapy Market Through 2029?
The market size for hormone therapy has seen substantial growth in the recent past. It is set to expand from $19.7 billion in 2024 to $20.9 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. The escalation during this historical period can be ascribed to advancements in the medical field, progress in women’s healthcare, a higher level of awareness and education, developments in clinical research, and a transformation in healthcare practices.
We anticipate a robust expansion of the hormone therapy market in the coming years, reaching an estimated $27.83 billion by 2029 with a compound annual growth rate (CAGR) of 7.4%. This predicted growth during the forecast period can be linked to several factors such as the adoption of personalized medicine, changing population age structure, transformation in women’s health strategies, emphasis on wellness and longevity, and regulatory modifications. Fundamental tendencies that play a role during the forecast period include shifts in regulatory policies and guidelines, lifestyle changes and stress levels, advances in research and development, and the growth of awareness and education.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9246&type=smp
What Market Forces Are Driving The Hormone Therapy Sector In 2025 And Beyond?
The hormone therapy market is experiencing significant growth due to a rise in hormone imbalance disorders. Hormone imbalance, a condition in which the body produces too much or too little of a hormone, can result in various disorders like hypothyroidism, hypogonadism, growth hormone deficiency, etc. Hormone therapies, including estrogen replacement, testosterone replacement, and insulin therapy, are utilized to address these disorders. A 2022 report from the London Medical Laboratory, a UK-based diagnostics and phlebotomy provider, projected a 19% increase in significant hormone imbalance cases compared to two years prior. As such, the incidence surge of hormone imbalance disorders will propel the hormone therapy market’s growth.
How Is The Global Hormone Therapy Market Categorized By Segments?
The hormone therapy market covered in this report is segmented –
1) By Therapy: Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
3) By Indication: Menopause, Hypothyroidism, Growth Hormone Deficiency, Other Indications
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies And Stores, Online Pharmacies
Subsegments:
1) By Estrogen Hormone Replacement: Systemic Estrogen Therapy, Local Estrogen Therapy, Combination Estrogen-Progestin Therapy
2) By Growth Hormone Replacement: Recombinant Growth Hormones, Synthetic Growth Hormones
3) By Thyroid Hormone Replacement: Levothyroxine, Liothyronine, Natural Desiccated Thyroid
4) By Testosterone Replacement: Injectable Testosterone, Transdermal Testosterone, Oral Testosterone, Pellets
What Notable Trends Are Shaping The Direction Of The Hormone Therapy Market?
Leading firms in the hormone therapy market are turning their focus towards creating innovative service delivery models, such as direct-to-consumer telehealth platforms, to improve patients’ access and make the process more convenient. This direct-to-consumer model in the context of hormone therapy signifies a health delivery system where patients can avail hormone therapy services from their remote locations without the need for face-to-face consultations. For instance, in September 2023, LifeMD, a US telehealth corporation, joined forces with ASCEND Therapeutics, a pharmaceutical company also based in the USA, to introduce an integrated telehealth system for hormone therapy with a keen emphasis on EstroGel (estradiol gel) catering to menopause symptoms. This alliance enables patients to directly utilize LifeMD’s telehealth solutions via the EstroGel website, which in turn expedites consultations with certified medical providers who can prescribe the medicine and organize its home delivery. By simplifying the process and addressing hindrances such as long waiting periods, this approach strives to enhance medical outcomes for women in need of menopause care.
Which Firms Are Considered Leaders In The Hormone Therapy Market Space?
Major companies operating in the hormone therapy market include Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, Pfizer Inc., Abbvie Inc., Teva Pharmaceutical Industries Ltd., Perrigo Company Plc., Cipla Inc., Lupin Limited, Sun Pharmaceuticals Industries Ltd., Hikma Pharmaceuticals PLC., Johnsons & Johnsons Services Inc., Boehringer Ingelheim International GmbH, Sanofi S.A., AstraZeneca plc, TherapeuticsMD Inc., Amgen Inc., Genentech Inc., Dr. Reddy’s Laboratories Ltd, Allergan PLC, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Daiichi Sankyo Company Limited
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report
What Role Do Regional Policies And Investments Play In Hormone Therapy Market Expansion?
North America was the largest region in the hormone therapy market in 2024. The regions covered in the hormone therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=9246&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model